LINC 2019 live case guide


Find all live cases and live case centers listed below.

 

 

Jena

4 livecase(s)
  • Wednesday, January 23rd: - , Room 3 - Technical Forum

    Case 45 – Selective internal radiation therapy in hepatocellular carcinoma

    Center:
    Jena
    Case 45 – JEN 01: male, 63 years (D-J)
    Operators:
    • René Aschenbach,
    • S. Witting,
    • R. Drescher
    CLINICAL DATA
    HCC Stage IIIa (pT3 Nx M0) 6/18
    Atypical segmentectomy segment III 6/18
    cTACE performed in referring hospital
    Multifocal HCC in both liver lobes
    Primary outside MILAN
    Universal liver tumor board waived sequential SIRT, starting right
    Evaluation showed a 2.5% shunt to the lung and estimated dose of 2.5GBq for Therasphere (BTG)
    No extrahepatic deposition of radioactivity in test-dose

    RISK FACTORS
    Liver cirrhosis CHILD A, MELD 6
    Diabetis mellitus, arterial hypertonia

    PROCEDURAL STEPS
    1. Right groin retrograde access
    - 0.035‘‘ EMERALD guidewire 150 cm (CORDIS)
    - 5F 10 cm Radiofocus Introducer II sheath (TERUMO)
    2. Placement of diagnostic catheter in main hepatic artery
    - 0.035‘‘Radiofocus angled guidewire, 180 cm (TERUMO)
    - Diagnostic catheter SIM 1, 4F 0.035‘‘, 100 cm (CORDIS)
    3. Placement of microcatheter in right hepatic artery
    - Progreat 2.7F (TERUMO)
    - alternative wire: Cirrus 14‘ (COOK)
    4. Radioembolisation
    - SIRT with TheraSphereR yttrium-90 glass microspheres (BTG)
    5. Puncture site occlusion
    - Vascularclosure Device Exoseal (CORDIS)
    View image
  • Wednesday, January 23rd: - , Room 3 - Technical Forum

    Case 46 – Transarterial chemoembolization with drug-eluting-beads (DEB-TACE) in hepatocellular carcinom

    Center:
    Jena
    Case 46 – JEN 02: female, 58 years (H-L)
    Operators:
    • René Aschenbach,
    • S. Witting
    CLINICAL DATA
    Differentiated hepatocellular carcinoma (G1)

    RISK FACTORS
    Liver cirrhosis CHILD A
    Chronische hepatitis

    PROCEDURAL STEPS
    1. Right groin retrograde access
    - 0.035‘‘ EMERALD guidewire 150 cm (CORDIS)
    - 5F 10 cm Radiofocus Introducer II sheath (TERUMO)
    2. Placement of diagnostic catheter in main hepatic artery
    - 0.035‘‘ Radiofocus angled guidewire, 180 cm (TERUMO)
    - Diagnostic catheter Cobra 4, 4F 0.035‘‘, 100 cm (CORDIS)
    3. Placement of microcatheter in right hepatic artery
    - Progreat 2.7F (TERUMO)
    - alternative wire: Cirrus 14‘ (COOK)
    4. Superselective placement of microcatheter in feeding artery
    5. Embolization
    - 40μm Embozene-Tandem (BOSTON SCIENTIFIC) loaded with 150 mg Doxorubicin till stasis
    6. If still perfusion after administration of the whole 3ml Embozene Tandem 40μm then additional embolization with blande microparticals Embozene 400μm till stasis is reached
    7. Control angiography
    8. Puncture site occlusion
    - Vascular closure device Exoseal (CORDIS) and pressure dressing
    View image
  • Wednesday, January 23rd: - , Room 3 - Technical Forum

    Case 49 – Prostatic artery embolization for symptomatic benign prostatic hyperplasia

    Center:
    Jena
    Case 49 – JEN 03: male, 58 years (M-K)
    Operators:
    • Tobias Franiel,
    • F. Bürckenmeyer
    CLINICAL DATA
    Prostatic volume 80 ml
    Negative TRUST-guided systematic biopsy due to increased PSA 6.0
    IPSS: 19 (0-35), QoL: 3 (0-6), Qmax: 13.0 ml/s with voided volume of 160 ml
    IIEF-5: 15 (1-25)

    RISK FACTORS
    Arterial hypertension

    DUPLEX
    Post void residual urine of 100ml

    PRESENT STATE
    Lower urinary tract symptoms due to BPH (confirmed by urology department)
    No successful medication therapy for more than 6 month, refusing operative therapy

    PROCEDURAL STEPS
    1. Right groin access
    - ST. JUDE (ABBOTT)
    2. Placement of coaxial catheter in distal aorta
    - RIM 4F (CORDIS) or alternative (MERRIT Medical)
    - Alternative wire: Cirrus 14“ (COOK)
    3. Large-FOV-dyna CT for determination of anatomy and origins of the prostatic arteries
    4. Placement of microcatheter in the left prostatic artery for embolization
    - Progreat 2.7F (TERUMO), alternative: Progreat 2.0F alpha (TERUMO), alternative SwiftNinja (MERRIT Medical)
    - Embozene 250 μm (BOSTON SCIENTIFIC), alternative: 400 μm (BOSTON SCIENTIFIC)
    5. Placement of the microcatheter in the right prostatic artery for embolization
    - Progreat 2.7F (TERUMO), alternative: Progreat 2.0F alpha (TERUMO), alternative SwiftNinja (MERRIT Medical)
    - Embozene 250 μm (BOSTON SCIENTIFIC)
  • Wednesday, January 23rd: - , Room 3 - Technical Forum

    Case 51 – Aneurysma embolization (coiling) of the splenic artery

    Center:
    Jena
    Case 51 – JEN 04: female, 74 years (V-S)
    Operators:
    • F. Bürckenmeyer,
    • I. Diamantis
    CLINICAL DATA
    16 mm neurysm of the lienal artery with growth tendency

    RISK FACTORS
    Arterial hypertension, rheumatoid arthritis

    PROCEDURAL STEPS
    1. Right groin retrograde access
    - 0.035‘‘ EMERALD guidewire 150 cm (CORDIS)
    - 5F 10 cm Radiofocus Introducer II sheath (TERUMO)
    2. Placement of diagnostic catheter in main hepatic artery
    - 0.035‘‘ Radiofocus angled guidewire, 180 cm (TERUMO)
    - Diagnostic catheter Cobra 4, 4F 0.035‘‘, 100 cm (CORDIS)
    3. Placement of microcatheter in splenic artery
    - Progreat 2.7F (TERUMO)
    - alternative wire: Cirrus 14‘ (COOK)
    4. Embolization
    - PENUMBRA Coils system
    5. Control angiography
    6. Puncture site occlusion
    - Vascular Closure System Exoseal (CORDIS) and pressure dressing
    View image